126 related articles for article (PubMed ID: 33540147)
1. Bioanalysis of erlotinib, its O-demethylated metabolites OSI-413 and OSI-420, and other metabolites by liquid chromatography-tandem mass spectrometry with additional ion mobility identification.
Rood JJM; Toraño JS; Somovilla VJ; Beijnen JH; Sparidans RW
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Mar; 1166():122554. PubMed ID: 33540147
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous determination of erlotinib and its isomeric major metabolites in human plasma using isocratic liquid chromatography-tandem mass spectrometry and its clinical application.
Ishida T; Naito T; Kawakami J
Biomed Chromatogr; 2015 May; 29(5):643-6. PubMed ID: 25296722
[TBL] [Abstract][Full Text] [Related]
3. A validated liquid chromatography tandem mass spectrometry method for quantification of erlotinib, OSI-420 and didesmethyl erlotinib and semi-quantification of erlotinib metabolites in human plasma.
Svedberg A; Gréen H; Vikström A; Lundeberg J; Vikingsson S
J Pharm Biomed Anal; 2015 Mar; 107():186-95. PubMed ID: 25594896
[TBL] [Abstract][Full Text] [Related]
4. The quantification of erlotinib (OSI-774) and OSI-420 in human plasma by liquid chromatography-tandem mass spectrometry.
Masters AR; Sweeney CJ; Jones DR
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 848(2):379-83. PubMed ID: 17101305
[TBL] [Abstract][Full Text] [Related]
5. Liquid chromatography-tandem mass spectrometric assay for therapeutic drug monitoring of the B-Raf inhibitor encorafenib, the EGFR inhibitors afatinib, erlotinib and gefitinib and the O-desmethyl metabolites of erlotinib and gefitinib in human plasma.
Sparidans RW; Rosing H; Rood JJM; Schellens JHM; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1033-1034():390-398. PubMed ID: 27639128
[No Abstract] [Full Text] [Related]
6. Specific method for determination of OSI-774 and its metabolite OSI-420 in human plasma by using liquid chromatography-tandem mass spectrometry.
Zhao M; He P; Rudek MA; Hidalgo M; Baker SD
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Aug; 793(2):413-20. PubMed ID: 12906916
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous Determination of Celecoxib, Erlotinib, and its Metabolite Desmethyl-Erlotinib (OSI-420) in Rat Plasma by Liquid chromatography/Tandem Mass Spectrometry with Positive/Negative Ion-Switching Electrospray Ionisation.
Thappali SR; Varanasi K; Veeraraghavan S; Arla R; Chennupati S; Rajamanickam M; Vakkalanka S; Khagga M
Sci Pharm; 2012; 80(3):633-46. PubMed ID: 23008811
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous quantification of atorvastatin, erlotinib and OSI-420 in rat serum and liver microsomes using a novel liquid chromatography-mass spectrometry method.
Rysz MA; Kinzi J; Schäfer AM; In-Albon K; Zürcher S; Schmidlin S; Seibert I; Schwardt O; Ricklin D; Meyer Zu Schwabedissen HE
J Pharm Biomed Anal; 2023 Nov; 236():115716. PubMed ID: 37722165
[TBL] [Abstract][Full Text] [Related]
9. In vitro drug metabolism of green tea catechins in human, monkey, dog, rat and mouse hepatocytes.
Chen WW; Qin GY; Zhang T; Feng WY
Drug Metab Lett; 2012 Jun; 6(2):73-93. PubMed ID: 22594564
[TBL] [Abstract][Full Text] [Related]
10. Quantitative determination of erlotinib and O-desmethyl erlotinib in human EDTA plasma and lung tumor tissue.
Lankheet NA; Schaake EE; Rosing H; Burgers JA; Schellens JH; Beijnen JH; Huitema AD
Bioanalysis; 2012 Nov; 4(21):2563-77. PubMed ID: 23173792
[TBL] [Abstract][Full Text] [Related]
11. Metabolite profiles of icariin in rat plasma by ultra-fast liquid chromatography coupled to triple-quadrupole/time-of-flight mass spectrometry.
Qian Q; Li SL; Sun E; Zhang KR; Tan XB; Wei YJ; Fan HW; Cui L; Jia XB
J Pharm Biomed Anal; 2012 Jul; 66():392-8. PubMed ID: 22522037
[TBL] [Abstract][Full Text] [Related]
12. Quantification of the tyrosine kinase inhibitor erlotinib in human scalp hair by liquid chromatography-tandem mass spectrometry: Pitfalls for clinical application.
Braal CL; Veerman GDM; Peric R; Aerts JGJV; Mathijssen RHJ; Koolen SLW; de Bruijn P
J Pharm Biomed Anal; 2019 Aug; 172():175-182. PubMed ID: 31051406
[TBL] [Abstract][Full Text] [Related]
13. Liquid-chromatographic determination of erlotinib (OSI-774), an epidermal growth factor receptor tyrosine kinase inhibitor.
Lepper ER; Swain SM; Tan AR; Figg WD; Sparreboom A
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Oct; 796(1):181-8. PubMed ID: 14552829
[TBL] [Abstract][Full Text] [Related]
14. Validation of an LC-MS/MS method for the quantitative determination of the orexin receptor antagonist almorexant and its four primary metabolites in human plasma.
Wagner-Redeker W; Finsterwald I; Dingemanse J
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Mar; 951-952():96-103. PubMed ID: 24531213
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a sensitive LC-MS/MS assay for the simultaneous quantification of allitinib and its two metabolites in human plasma.
Lin L; Gao Z; Chen X; Zhong D
J Pharm Biomed Anal; 2013 Dec; 86():49-55. PubMed ID: 23973791
[TBL] [Abstract][Full Text] [Related]
16. Determination of the sulfate and glucuronide conjugates of levornidazole in human plasma and urine, and levornidazole and its five metabolites in human feces by high performance liquid chromatography-tandem mass spectrometry.
He G; Guo B; Zhang J; Li Y; Wu X; Fan Y; Chen Y; Cao G; Yu J
J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Apr; 1081-1082():87-100. PubMed ID: 29518721
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo metabolism of verproside in rats.
Kim MG; Hwang DK; Jeong HU; Ji HY; Oh SR; Lee Y; Yoo JS; Shin DH; Lee HS
Molecules; 2012 Oct; 17(10):11990-2002. PubMed ID: 23085650
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of the new anxiolytic agent, a pyrido[1,2-]benzimidazole (PBI) analog (RWJ-53050), in rat and human hepatic S9 fractions, and in dog; identification of cytochrome p450 isoforms mediated in the human microsomal metabolism.
Wu WN; McKown LA; Reitz AB
Eur J Drug Metab Pharmacokinet; 2006; 31(4):277-83. PubMed ID: 17315539
[TBL] [Abstract][Full Text] [Related]
19. Identification of in vitro metabolites of JWH-015, an aminoalkylindole agonist for the peripheral cannabinoid receptor (CB2) by HPLC-MS/MS.
Zhang Q; Ma P; Cole RB; Wang G
Anal Bioanal Chem; 2006 Nov; 386(5):1345-55. PubMed ID: 16955257
[TBL] [Abstract][Full Text] [Related]
20. Rapid determination of gefitinib and its main metabolite, O-desmethyl gefitinib in human plasma using liquid chromatography-tandem mass spectrometry.
Wang LZ; Lim MY; Chin TM; Thuya WL; Nye PL; Wong A; Chan SY; Goh BC; Ho PC
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(22):2155-61. PubMed ID: 21703945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
